Am80 (tamibarotene) and ATRA induce highly similar molecular responses and myeloid differentiation in non-APL AML, enhanced by LSD1/GCN5 inhibition and increased RARA expression - Quiz - MDSpire

Am80 (tamibarotene) and ATRA induce highly similar molecular responses and myeloid differentiation in non-APL AML, enhanced by LSD1/GCN5 inhibition and increased RARA expression

  • By

  • Faezeh Ghazvini Zadegan

  • Clara Stanko

  • Franziska Fiedler

  • Laura Ölsner

  • Setenay Gupse Özcan

  • Jacqueline Schütt

  • Tina M. Schnöder

  • Yordan Sbirkov

  • Lukasz Szymanski

  • Sven Stengel

  • Peter Dittrich

  • Jörg P. Müller

  • Florian H. Heidel

  • Andreas Hochhaus

  • Sebastian Scholl

  • Ulf Schnetzke

  • Annamaria Brioli

  • Tino Schenk

  • June 27, 2026

  • 0 min

Share

Original Source(s)

Am80 (tamibarotene) and ATRA induce highly similar molecular responses and myeloid differentiation in non-APL AML, enhanced by LSD1/GCN5 inhibition and increased RARA expression

  • by Faezeh Ghazvini Zadegan, Clara Stanko, Franziska Fiedler, Laura Ölsner, Setenay Gupse Özcan, Jacqueline Schütt, Tina M. Schnöder, Yordan Sbirkov, Lukasz Szymanski, Sven Stengel, Peter Dittrich, Jörg P. Müller, Florian H. Heidel, Andreas Hochhaus, Sebastian Scholl, Ulf Schnetzke, Annamaria Brioli, Tino Schenk

  • June 27, 2026

Related Content

Technetium-99m-marked sentinel lymph node biopsy for oral squamous cell carcinoma as a safe and effective procedure for patient and staff

ESMO Breast Cancer 2026 Highlights: Pumitamig + DB-1305/BNT325

Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD discuss results from the Pumitamig + DB-1305/BNT325 trial, which were presented at the 2026 ESMO Breast Cancer Congress.

  • June 26, 2026

  • 1 min
Chemical components of tattoo inks and their potential role in carcinogenesis and their side effects